Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012;17(2):149-50.
doi: 10.1634/theoncologist.2012-0004. Epub 2012 Feb 2.

Call it cancer

Bruce A Chabner, Matthew Smith
Editorial

Call it cancer

Bruce A Chabner et al. Oncologist. 2012.

Abstract

The findings of the National Institutes of Health State-of-the-Science Conference on the role of active surveillance in the management of men with localized prostate cancer are examined.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Bruce A. Chabner: Massachusetts General Hospital, Harvard (E); Sanofi, Redwood, Allergan, Epizyme, PharmaMar, GlaxoSmithKline (pending) (C/A); Eli Lilly (H); U.S. Government (RF); PharmaMar, Gilead, Merck, Epizyme, Human Genome Sciences, Curis, Onyx, Rigel, Bristol-Myers Squibb (OI); Matthew Smith: None.

Comment in

References

    1. Melville H. Moby-Dick: or, The Whale. New York, NY: Penguin Classics; 2001.
    1. Ganz PA, Barry JM, Burke W, et al. National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men with Localized Prostate Cancer. [accessed December 11, 2011]. Available at http://consensus.nih.gov/2011/docs/prostate/ASPC Final Draft Statement.pdf. - PMC - PubMed
    1. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185–191. - PubMed
    1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–236. - PubMed
    1. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–1328. - PubMed

Publication types

Substances